Modulation of Neurolipid Signaling and Specific Lipid Species in the Triple Transgenic Mouse Model of Alzheimer’s Disease
Alzheimer’s disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia in aging populations. Recently, the regulation of neurolipid-mediated signaling and cerebral lipid species was shown in AD patients. The triple transgenic mouse model (3xTg-AD), harboring βAPP&...
Guardado en:
Autores principales: | Estibaliz González de San Román, Alberto Llorente-Ovejero, Jonatan Martínez-Gardeazabal, Marta Moreno-Rodríguez, Lydia Giménez-Llort, Iván Manuel, Rafael Rodríguez-Puertas |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/74df66c978ad4466922187f854e95fa9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Sphingosine Kinase 1 Signaling in Breast Cancer: A Potential Target to Tackle Breast Cancer Stem Cells
por: Ling-Wei Hii, et al.
Publicado: (2021) -
1,2,3-Triazole derivatives as highly selective cannabinoid receptor type 2 (CB2) agonists
por: Amer H. Tarawneh, et al.
Publicado: (2022) -
Signaling through the S1P−S1PR Axis in the Gut, the Immune and the Central Nervous System in Multiple Sclerosis: Implication for Pathogenesis and Treatment
por: Simela Chatzikonstantinou, et al.
Publicado: (2021) -
Sistema endocanabinoide y desarrollo de esteatosis hepática
por: Valenzuela,Carina, et al.
Publicado: (2014) -
Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome
por: Estelle Gerossier, et al.
Publicado: (2021)